Procainamide
- TRADE NAMES: Amisalen; Biocoryl; Procan (Pfizer); Procan SR; Procanbid (Pfizer); Promine; Pronestyl; Rhythmin; Ritmocamid
- INDICATIONS: Ventricular arrhythmias
- CLASS: Antiarrhythmic, Antiarrhythmic class Ia
- HALF-LIFE: 2.5–4.5 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Abarelix, Amiodarone, Amisulpride, Arsenic, Artemether/Lumefantrine, Asenapine, Astemizole, Ciprofloxacin, Enoxacin, Ethoxzolamide, Gatifloxacin, Glycopyrrolate, Glycopyrronium, Imidapril, Lomefloxacin, Lurasidone, Metformin, Mivacurium, Moxifloxacin, Nilotinib, Norfloxacin, Ofloxacin, Pimavanserin, Ponesimod, Quinine, Quinolones, Ribociclib, Rocuronium, Sotalol, Sparfloxacin, Tetrabenazine, Trimethoprim, Trospium, Vandetanib, Zofenopril
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
